Trials / Conditions / Atherosclerotic Vascular Disease
Atherosclerotic Vascular Disease
5 registered clinical trials studyying Atherosclerotic Vascular Disease — 1 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Recruiting | Inclisiran (Leqvio®) in Patients With Atherosclerotic Vascular Disease and/or Heterozygous Familial Hyperchole NCT06958315 | Novartis Pharmaceuticals | — |
| Completed | The Effects of Evolocumab in Patients With Diabetes and Atherosclerotic Vascular Disease NCT03829046 | Robert Rosenson | Phase 4 |
| Completed | Colchicine in Vascular Inflammation Assessed With PET Imaging NCT02162303 | Montreal Heart Institute | Phase 2 |
| Active Not Recruiting | Genetic Testing of CYP2C19 in Prognostic Evaluation of Long-Term Major Adverse Cardiac and Vascular Events NCT06855394 | University of Florida | — |
| Completed | Evaluate the Utility of 18FDG-PET as a Tool to Quantify Atherosclerotic Plaque (MK-0000-081 AM3)(COMPLETED) NCT00703261 | Merck Sharp & Dohme LLC | Phase 1 |